Document 0126 DOCN M94A0126 TI Human immunodeficiency virus infection and tuberculosis: an analysis and a course of action. DT 9412 AU Bryt AB; Rogers DE; Cornell University Medical College, New York, NY 10021. SO Bull N Y Acad Med. 1994 Summer;71(1):18-36. Unique Identifier : AIDSLINE MED/94348475 AB Tuberculosis, once on the steady decline in the western world, has resurfaced with renewed vigor in the wake of the human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) epidemic. People with HIV infection are both more likely to contract primary tuberculosis and at greater risk for reactivation of latent tuberculosis. Tuberculous disease may present with atypical signs and symptoms in HIV-infected hosts because of alterations in the immune system. Superimposed on the virulent interaction of HIV and tuberculosis is the emerging problem of multidrug resistant strains that often resist currently available therapies. HIV-positive health professionals working in high-risk environments pose a special problem, while populations unable to comply with currently available pharmacological therapies pose another. We have many tools available to combat the resurgence of tuberculosis, but new methods of diagnosis and new approaches to treatment are sorely needed. DE Acquired Immunodeficiency Syndrome/*COMPLICATIONS Comorbidity Disease Transmission, Patient-to-Professional/PREVENTION & CONTROL Health Personnel Human Incidence Mass Screening Patient Compliance Population Density Prevalence Recurrence Skin Tests/METHODS Tuberculosis/*COMPLICATIONS/DIAGNOSIS/DRUG THERAPY/EPIDEMIOLOGY/ PREVENTION & CONTROL/TRANSMISSION Tuberculosis, Multidrug-Resistant/COMPLICATIONS/PREVENTION & CONTROL/PHYSIOPATHOLOGY JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).